Treatment of the chronic hepatitis B virus carrier state.
J Infect
; 16(3): 221-9, 1988 May.
Article
em En
| MEDLINE
| ID: mdl-2456355
ABSTRACT
Chronic hepatitis B is no longer untreatable. With the advent of powerful antiviral agents such as adenine arabinoside, and, more importantly, with recombinant DNA technology and advanced culture systems able to produce large quantities of interferons, the prospects for treating patients with chronic hepatitis B virus (HBV) infection have changed completely. In the U.K., carriers not infected at birth are currently being treated with an approximately 50% chance of permanently inhibiting viral replication. In some of these, viral markers appear to be completely eliminated.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Fosfato de Vidarabina
/
Arabinonucleotídeos
/
Vidarabina
/
Portador Sadio
/
Interferons
/
Hepatite B
Limite:
Humans
Idioma:
En
Ano de publicação:
1988
Tipo de documento:
Article